Dr. Elisabeth Lackner is CEO of ABF and the Global Head EVP of the GBA Group Pharma. Elisabeth graduated in pharmacy and holds a PhD and Master's degree in tumor biology. Her experience stems from having spent more than 15 years in the clinical research industry spanning basic research, sales, marketing, business development, global operations and project management roles. Prior to joining ABF, Elisabeth held a senior management role at Roche and was the Head of Manufacturing for five years. Having worked in different fields of clinical research for CROs, pharmaceutical and biotechnology companies she brings the perfect perspective to the supply chain and to the expertise of ABF.
Monique Stock is the Site Manager at ABF and joined the company in 2017. Monique has over 20 years of professional experience in pharmaceutical industry spanning from manufacturing, development and project management roles. Prior to joining ABF, Monique held a senior management position at Croma Pharma GmbH.
Daniel Siderits is Head of Quality Assurance and Quality Control at ABF Pharmaceutical Services. In addition, he is the responsible person for narcotics handling and legal representative for controlled drugs at ABF. Daniel graduated in biology and gained experience in quality and clinical research after having spent more than five years in research at university and in quality control.
Martin Schmuck joined ABF in 2015 as Head of Finance. Before joining ABF he held various senior positions in Finance & Controlling.